Quick answer
How can the quality of MT-2 (Melanotan II) research material be judged? Quality for a cyclic lactam peptide comes down to four checkable things: that the label, lot number and certificate describe the same material; that the HPLC purity figure comes from a chromatogram whose method is stated; that the impurities typical of this molecule (uncyclized precursor, deletion sequences, a D→L phenylalanine diastereomer, oxidized tryptophan) are resolved or at least acknowledged; and that the vial looks and behaves as expected on opening. The V8 product page lists MT-2 as a 10 mg lyophilized vial, sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, formula C50H69N15O9, with a purity specification of ≥98% by HPLC. This guide walks through each check. For laboratory research use only.
Questions about "MT2 quality" tend to get generic answers about purity percentages. A number alone is a weak measure, because the same headline figure can hide very different impurity profiles. This article uses the specific chemistry of Melanotan II to explain what a careful receiving check looks at and what each result means. It complements the more general pieces on Melanotan II purity testing and the Melanotan II research overview. It concerns laboratory material only; the compound is for laboratory research use only and not for human consumption.
What a quality claim should be built on
A reliable quality record has a chain of evidence from the vial in hand back to an analytical report. The chain is only as strong as its weakest link, and the links are easy to inspect.
| Link in the chain | What to confirm | Why it matters |
|---|---|---|
| Label | Compound name, size, lot number and research-use-only statement are present and legible | Ties the vial to a lot |
| Lot number | Matches the certificate and the packing paperwork | A certificate for a different lot says nothing about this one |
| Certificate | Names the compound, method, test date and the measured result, not just a specification | A specification is a target; a measured value is a result |
| Chromatogram | Shows the main peak, baseline and any minor peaks, with column, gradient and wavelength stated | A purity figure depends on the method that produced it |
| Identity | Reports how identity was established, for instance retention against a reference or a mass-based measurement | Purity of the wrong molecule is not quality |
| Physical condition | Seal intact, powder appearance as expected | Detects shipping and storage damage |
The V8 product page states that batch-specific analytical documentation supports receiving, verification and internal recordkeeping; where a certificate has been published it can be found in the COA library. How to read a COA and third-party testing explained describe the fields in more detail.
Impurities specific to a cyclic lactam peptide
Melanotan II is a cyclic heptapeptide in which the side chains of aspartic acid and lysine are joined by a lactam bridge, designed by Al-Obeidi, Hruby, Hadley and co-workers in 1989 as a potent and prolonged-acting analog of α-melanotropin. Synthesis involves building a linear precursor on resin, closing the ring, cleaving, and purifying; large-scale chemical synthesis of peptides in general is reviewed by Bray (2003). Each stage leaves its own possible by-products.
Uncyclized linear precursor
If ring closure is incomplete, the open-chain peptide remains. It has the same sequence and almost the same mass (the lactam formation removes one water, about 18 Da), but a free carboxylate and amine, so it is usually more polar and elutes earlier on reverse-phase HPLC. A mass-based identity measurement distinguishes the two by that 18 Da difference.
Deletion and truncation sequences
Failed coupling at any step produces a peptide missing one residue. Because the molecule is only seven residues long, each deletion changes the mass substantially and usually changes retention, which makes them visible as small peaks near the main one.
The D-phenylalanine position
The D-Phe residue is central to the high potency of the cyclic analogs. During synthesis, amino acids can epimerize; if some D-Phe converts to L-Phe, the product is a diastereomer with identical mass and nearly identical retention. Diastereomers often co-elute on a standard gradient or appear as a shoulder, which is a reason a single clean-looking peak is not proof of stereochemical purity. A shallow gradient or a different column can separate them.
Oxidized tryptophan
Tryptophan is the residue most exposed to oxidation and light in this molecule. Oxidation products add 16 or 32 Da, and ring-opened products such as N-formylkynurenine are often yellow. Kerwin and Remmele (2007) discuss photodegradation of tryptophan in protein biologics, and the same chemistry applies to peptides. A freshly lyophilized cake should be white to off-white; a distinct yellow cast is worth recording.
Counterions and water
Purified peptides are salts, commonly of trifluoroacetic acid or acetic acid, and hold some bound water. The measured net peptide content may therefore be well below the weighed fill mass. This is normal, but it affects molar concentration, and it matters for sensitive cell work because residual trifluoroacetate has been reported to inhibit proliferation in some cultured cells (Cornish and colleagues, 1999). The product page does not state the salt form, so check the certificate.
| Possible impurity | Mass change vs. target | Typical HPLC behavior | Detection |
|---|---|---|---|
| Uncyclized linear precursor | +18 Da | Usually earlier | Mass-based identity; retention |
| Deletion sequence | Minus the missing residue | Shifted, minor peak | Mass-based identity; retention |
| L-Phe diastereomer | None | Co-elutes or shoulder | Shallow gradient, alternative column |
| Tryptophan oxidation | +16 / +32 Da | Often earlier, may be colored | Retention, UV spectrum, mass |
| Counterion or water | Not a peptide species | Invisible to peptide-bond UV | Net peptide content assay, where reported |
Reading a purity figure properly
Purity by HPLC is usually reported as the area of the main peak divided by the total area of all peaks at one wavelength, commonly 214 nm where the peptide bond absorbs. Three consequences follow. Species that do not absorb at that wavelength, including salts and water, are invisible. Species that co-elute with the main peak are counted as the main peak. And the figure depends on integration choices, such as where the baseline is drawn. Understanding HPLC purity expands on these points, and HPLC compared with mass-based identity testing explains why the two measurements answer different questions.
When a certificate shows only a percentage, with no chromatogram or method, regard it as incomplete. Red flags when buying research peptides and vetting a research peptide supplier list other signs worth noting.
A receiving check at the bench
- Inspect the package. Seal, crimp, label and any signs of moisture. Photograph anything unusual.
- Record the lot. Write the lot number, size and receipt date in the lab log and match it to the certificate. The MT-2 product page gives the expected sequence, formula and size to check against.
- Look at the powder. A thin white disc or loose white powder is typical for 10 mg. Residue that is wet, gummy or yellow should be noted before use; peptide vial appearance shows what is normal.
- Store immediately. The page states refrigerate at 2–8 °C, −20 °C for long-term, protected from heat, moisture and light.
- Reconstitute one test vial. Note clarity, color and the time to full dissolution. Concentration is vial mass divided by diluent volume; use the calculator.
- Run an in-house check if the work is sensitive. A short HPLC run on the first preparation, with the chromatogram filed, provides a baseline for later comparison.
Stability behavior after this first check is described in how long reconstituted peptides last, and the broader storage rules in storing research peptides. A comparison with the related linear and cyclic melanocortin ligands is in the PT-141 vs Melanotan II comparison.
Quality after the vial is opened
Quality is not fixed at receipt. Once the powder is dissolved, the lactam ring is stable, but the tryptophan side chain, the histidine and the surfaces of the container remain relevant. A stock kept cold, dark and in single-use aliquots will usually still match its first chromatogram weeks later; a stock left on a bench in clear glass may not. Comparing a late chromatogram with the first one, at the same wavelength and gradient, is the simplest way to see whether a new impurity peak has appeared. Concentration can also fall without any chemical change when peptide adsorbs to glass or polypropylene, so a drop in assay response is not always a drop in purity. Recording both the analytical comparison and the assay response, with dates, makes it possible to tell the two apart.
What quality checks cannot establish
Analytical quality describes the material, not its behavior in a given experiment. A pure, correctly identified lot can still give a poor result if the stock is handled badly, if the assay is insensitive or if the receptor system differs from the one in the published studies. Quality also says nothing about suitability for any use outside the laboratory; the product is for laboratory research use only. The history of the molecule, including the design work reported by Hadley and Dorr (2006), is background for choosing controls and not a guide to use. Other materials are listed in the shop.
Frequently asked questions
What does the product page say about MT-2?
It lists a 10 mg lyophilized vial, sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, molecular formula C50H69N15O9 and a purity specification of ≥98% by HPLC.
Is a purity percentage enough to judge quality?
No. The same figure can come from different methods and hide different impurities. A chromatogram with its method, and an identity result, give a fuller picture.
What impurities are specific to Melanotan II?
Uncyclized linear precursor, deletion sequences, an L-phenylalanine diastereomer, oxidized tryptophan, and counterion or water content that does not show in peptide HPLC.
Why can a diastereomer be missed?
It has the same mass and nearly the same retention as the target, so it may co-elute or appear as a shoulder. A shallow gradient or different column can separate it.
What should the powder look like?
White to off-white, as a thin disc or loose powder. Wet, gummy or yellow residue should be recorded before use.
Why can a yellow tint matter?
Oxidation of tryptophan can produce colored ring-opened products, and the effect is accelerated by light and warmth.
What is net peptide content?
The fraction of the fill mass that is peptide rather than counterion and bound water. It matters when exact molar concentrations are needed.
Where are certificates found?
In the COA library, where one has been published for the lot. Match the lot number on the label to the certificate.
How is the sealed vial stored?
The product page states 2–8 °C, with −20 °C for the long term, protected from heat, moisture and light.
Is MT-2 intended for use in people or animals?
No. It is supplied for laboratory research use only and is not for human or animal consumption.
References
- Al-Obeidi F, Castrucci AM, Hadley ME, Hruby VJ. Potent and prolonged-acting cyclic lactam analogs of α-melanotropin: design based on molecular dynamics. J Med Chem. 1989;32(12):2555-2561. doi:10.1021/jm00132a010
- Al-Obeidi F, Hadley ME, Pettitt BM, Hruby VJ. Design of a new class of superpotent cyclic α-melanotropins based on quenched dynamic simulations. J Am Chem Soc. 1989;111(9):3413-3416. doi:10.1021/ja00191a044
- Hadley ME, Dorr RT. Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides. 2006;27(4):921-930. doi:10.1016/j.peptides.2005.01.029
- Kerwin BA, Remmele RL Jr. Protect from light: photodegradation and protein biologics. J Pharm Sci. 2007;96(6):1468-1479. doi:10.1002/jps.20815
- Cornish J, Callon KE, Lin CQ, Xiao CL, Mulvey TB, Cooper GJ, Reid IR. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol Endocrinol Metab. 1999;277(5):E779-E783. doi:10.1152/ajpendo.1999.277.5.E779
- Bray BL. Large-scale manufacture of peptide therapeutics by chemical synthesis. Nat Rev Drug Discov. 2003;2(7):587-593. doi:10.1038/nrd1133
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6
- Goebel-Stengel M, Stengel A, Taché Y, Reeve JR Jr. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011;414(1):38-46. doi:10.1016/j.ab.2011.02.009
